| Takeda Pharma AG - Mezavant, 1,2 g magensaftresistente Retardtabletten | | 65811 | | 01 | | Mezavant, 1,2 g magensaftresistente Retardtabletten | | | | A07EC02 | | Mesalazin | | 30.08.2016 | | |
| | Composition | | mesalazinum 1.2 g, carmellosum natricum, cera carnauba, acidum stearicum, silica colloidalis hydrica, carboxymethylamylum natricum A, talcum, magnesii stearas, Überzug: talcum, acidi methacrylici copolymerum A, acidi methacrylici copolymerum B, triethylis citras, macrogolum 6000, E 171, E 172 (rubrum) pro compresso obducto corresp. natrium 5.66 mg. | | Packungsbestandteile | | Principe actif | Concentr. |
|---|
| Mesalazine | 1.2 g |
| | BAG: Principe actif | Concentr. |
|---|
| Mesalazine | 1.2 g |
| | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Rubrum) pro Compresso Obducto | | | | Acidi Methacrylici Copolymerum A | | | | Acidi Methacrylici Copolymerum B | | | | Acidum Stearicum | | | | Carboxymethylamylum Natricum A | | | | Carmellose Sodique | | | | Cera Carnauba | | | | E 171 | | color. | | E 172 | | color. | | Macrogol | 6000 | | | Magnesii Stearas | | | | Silica Colloidalis Hydrica | | | | Talcum | | Überzug | | Triethylis Citras | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 60 | 47.32 | 67.90 | B | LS | Oui |
|
|
